Capital World Investors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-767,000
Closed -$14.3M 608
2025
Q2
$14.3M Hold
767,000
﹤0.01% 487
2025
Q1
$14.7M Hold
767,000
﹤0.01% 471
2024
Q4
$27.6M Sell
767,000
-2,498,300
-77% -$84.5M ﹤0.01% 447
2024
Q3
$138M Sell
3,265,300
-400,000
-11% -$17M 0.02% 315
2024
Q2
$148M Hold
3,665,300
0.02% 300
2024
Q1
$130M Sell
3,665,300
-2,718,811
-43% -$72.8M 0.02% 321
2023
Q4
$189M Sell
6,384,111
-161,227
-2% -$3.34M 0.03% 282
2023
Q3
$136M Buy
6,545,338
+59,311
+0.9% +$1.63M 0.03% 304
2023
Q2
$159M Buy
6,486,027
+529,497
+9% +$17M 0.03% 293
2023
Q1
$242M Buy
5,956,530
+1,106,346
+23% +$45.8M 0.05% 261
2022
Q4
$218M Buy
4,850,184
+294,581
+6% +$13.3M 0.05% 265
2022
Q3
$218M Buy
4,555,603
+1,699,426
+60% +$93.2M 0.05% 259
2022
Q2
$169M Buy
2,856,177
+9,925
+0.3% +$815K 0.04% 292
2022
Q1
$331M Sell
2,846,252
-580,877
-17% -$67.8M 0.06% 246
2021
Q4
$516M Buy
3,427,129
+133,133
+4% +$18M 0.08% 210
2021
Q3
$393M Buy
3,293,996
+17,292
+0.5% +$1.91M 0.07% 236
2021
Q2
$319M Buy
3,276,704
+188,425
+6% +$16.8M 0.05% 257
2021
Q1
$273M Buy
3,088,279
+15,315
+0.5% +$1.42M 0.05% 259
2020
Q4
$294M Buy
3,072,964
+1,518,075
+98% +$156M 0.06% 244
2020
Q3
$176M Buy
1,554,889
+736,387
+90% +$77.4M 0.04% 277
2020
Q2
$81M Buy
+818,502
New +$65.3M 0.02% 323

Other funds holding TNDM

Capital World Investors's TNDM Position: Q3 2025 in Review

Capital World Investors sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 767,000 shares — an estimated $14.3M sold.

Capital World Investors first reported a position in TNDM in Q2 2020 and held it in 21 quarters. The position peaked at $516M in Q4 2021. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Capital World Investors reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Capital World Investors sold 767,000 Tandem Diabetes Care shares in Q3 2025, an estimated $14.3M.
  • Capital World Investors first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 21 quarters.
  • Capital World Investors's Tandem Diabetes Care position peaked at $516M in Q4 2021.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Capital World Investors's 13F filing for Q3 2025, filed 13 Nov 2025.